34KIT
A whole lot easier!
How NeedleBay is revolutionising diabetes management
when it comes to using insulin pen needles.
advertorial - sponsored by NeedleBay
In the world of diabetes care,
innovation is key to improving the
quality of life for millions of people
living with the condition. One
such innovation making waves is the
NeedleBay system, a solution designed
to simplify insulin administration
and ensure medication adherence.
After years of thorough trials and
insightful research, NeedleBay has
come a long way since its initial
development, proving to be a gamechanger
in diabetes management.
As we look back at its journey, from
trials at Cardiff University to an indepth analysis
by the University of
Reading, it's clear that this product is
poised to transform how diabetes is
managed globally.
Sticking to the plan
For many people with diabetes,
sticking to a prescribed medication
routine is critical, yet challenging.
Non-compliance with insulin
regimens (referred to as medication
adherence) can lead to diabetesrelated
complications and increased
healthcare costs, which in the UK
alone exceed £3bn annually. The
NeedleBay system was designed with
these challenges in mind, offering
a simple, intuitive way to manage
insulin pen needles and ensure
timely, accurate dosing.
A key trial at the Cardiff University
School of Healthcare Sciences
involved more than 250 participants
and was aimed to assess whether
NeedleBay could help them better
manage their insulin usage, keeping
them on track with their medication
schedules. The results were
promising - patients found it easier
to adhere to their regimens, and
the system significantly improved
medication management.
NeedleBay has now developed
a new and improved version of
the system, this updated version
includes four pen needle bays and
incorporates feedback from both
users and researchers. The result is
a system that promises up to an 88%
improvement in the self-management
of diabetes medication.
Initially available in the UK, this